Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002542954 | SCV003575401 | uncertain significance | Inborn genetic diseases | 2021-08-23 | criteria provided, single submitter | clinical testing | The c.503T>C (p.V168A) alteration is located in exon 5 (coding exon 5) of the PSAP gene. This alteration results from a T to C substitution at nucleotide position 503, causing the valine (V) at amino acid position 168 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001280279 | SCV001467444 | uncertain significance | Metachromatic leukodystrophy | 2020-04-11 | no assertion criteria provided | clinical testing |